Klingkowski U, Huth R G, Habermehl P, Knuf M
Pädiatrische Immunologie und Infektiologie, Interdisziplinäre Kinderintensivmedizin, Kinderklinik der Johannes Gutenberg-Universität Mainz.
Klin Padiatr. 2004 Jan-Feb;216(1):21-3. doi: 10.1055/s-2004-817683.
The use of the antibiotic Linezolid in two premature babies with necrotizing enterocolitis and infection with vancomycin-resistant enterococcus is described. Therapy with Linezolid in cause of necrotizing enterocolitis is an exception. Actually there are no proven recommendations for the use in this age group. Despite the successfully results more investigations for the use of linezolid in newborns and prematures are necessary.
描述了在两名患有坏死性小肠结肠炎且感染耐万古霉素肠球菌的早产儿中使用抗生素利奈唑胺的情况。在坏死性小肠结肠炎病例中使用利奈唑胺进行治疗是个例外。实际上，对于该年龄组的使用并无经证实的推荐意见。尽管取得了成功的结果，但仍有必要对利奈唑胺在新生儿和早产儿中的使用进行更多研究。
